Copyright Reports & Markets. All rights reserved.

Global Oncology Anti-Cancer Drugs Market Research Report 2012-2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Objectives of Research
      • 1.1.1 Definition
      • 1.1.2 Specifications
    • 1.2 Market Segment
      • 1.2.1 by Type
        • 1.2.1.1 Chemotherapy
        • 1.2.1.2 Targeted Therapy
        • 1.2.1.3 Immunotherapy (Biologic Therapy)
        • 1.2.1.4 Hormonal Therapy
        • 1.2.1.5 Others
      • 1.2.2 by Application
        • 1.2.2.1 Blood Cancer (Leukaemia)
        • 1.2.2.2 Breast Cancer
        • 1.2.2.3 Gastrointestinal Cancer
        • 1.2.2.4 Respiratory/Lung Cancer
        • 1.2.2.5 Skin Cancer
        • 1.2.2.6 Other Cancers
      • 1.2.3 by Regions

    2 Industry Chain

    • 2.1 Industry Chain Structure
    • 2.2 Upstream
    • 2.3 Market
      • 2.3.1 SWOT
      • 2.3.2 Dynamics

    3 Environmental Analysis

    • 3.1 Policy
    • 3.2 Economic
    • 3.3 Technology
    • 3.4 Market Entry

    4 Market Segmentation by Type

    • 4.1 Market Size
      • 4.1.1 Chemotherapy Market, 2013-2018
      • 4.1.2 Targeted Therapy Market, 2013-2018
      • 4.1.3 Immunotherapy (Biologic Therapy) Market, 2013-2018
      • 4.1.4 Hormonal Therapy Market, 2013-2018
      • 4.1.5 Others Market, 2013-2018
    • 4.2 Market Forecast
      • 4.2.1 Chemotherapy Market Forecast, 2019-2024
      • 4.2.2 Targeted Therapy Market Forecast, 2019-2024
      • 4.2.3 Immunotherapy (Biologic Therapy) Market Forecast, 2019-2024
      • 4.2.4 Hormonal Therapy Market Forecast, 2019-2024
      • 4.2.5 Others Market Forecast, 2019-2024

    5 Market Segmentation by Application

    • 5.1 Market Size
      • 5.1.1 Blood Cancer (Leukaemia) Market, 2013-2018
      • 5.1.2 Breast Cancer Market, 2013-2018
      • 5.1.3 Gastrointestinal Cancer Market, 2013-2018
      • 5.1.4 Respiratory/Lung Cancer Market, 2013-2018
      • 5.1.5 Skin Cancer Market, 2013-2018
      • 5.1.6 Other Cancers Market, 2013-2018
    • 5.2 Market Forecast
      • 5.2.1 Blood Cancer (Leukaemia) Market Forecast, 2019-2024
      • 5.2.2 Breast Cancer Market Forecast, 2019-2024
      • 5.2.3 Gastrointestinal Cancer Market Forecast, 2019-2024
      • 5.2.4 Respiratory/Lung Cancer Market Forecast, 2019-2024
      • 5.2.5 Skin Cancer Market Forecast, 2019-2024
      • 5.2.6 Other Cancers Market Forecast, 2019-2024

    6 Market Segmentation by Region

    • 6.1 Market Size
      • 6.1.1 Asia-Pacific
        • 6.1.1.1 Asia-Pacific Market, 2012-2018
        • 6.1.1.2 Asia-Pacific Market by Type
        • 6.1.1.3 Asia-Pacific Market by Application
      • 6.1.2 North America
        • 6.1.2.1 North America Market, 2012-2018
        • 6.1.2.2 North America Market by Type
        • 6.1.2.3 North America Market by Application
      • 6.1.3 Europe
        • 6.1.3.1 Europe Market, 2012-2018
        • 6.1.3.2 Europe Market by Type
        • 6.1.3.3 Europe Market by Application
      • 6.1.4 South America
        • 6.1.4.1 South America Market, 2012-2018
        • 6.1.4.2 South America Market by Type
        • 6.1.4.3 South America Market by Application
      • 6.1.5 Middle East & Africa
        • 6.1.5.1 Middle East & Africa Market, 2012-2018
        • 6.1.5.2 Middle East & Africa Market by Type
        • 6.1.5.3 Middle East & Africa Market by Application
    • 6.2 Market Forecast
      • 6.2.1 Asia-Pacific Market Forecast, 2019-2024
      • 6.2.2 North America Market Forecast, 2019-2024
      • 6.2.3 Europe Market Forecast, 2019-2024
      • 6.2.4 South America Market Forecast, 2019-2024
      • 6.2.5 Middle East & Africa Market Forecast, 2019-2024

    7 Market Competitive

    • 7.1 Global Market by Vendors
    • 7.2 Market Concentration
    • 7.3 Price & Factors
    • 7.4 Marketing Channel

    8 Major Vendors

    • 8.1 Amgen
    • 8.2 AstraZeneca
    • 8.3 Roche Diagnostics
    • 8.4 GlaxoSmithKline
    • 8.5 Merck
    • 8.6 Novartis
    • 8.7 AbbVie
    • 8.8 Sanofi
    • 8.9 EIMC United Pharmaceuticals
    • 8.10 Actavis

    9 Conclusion

    Summary
    The global Oncology Anti-Cancer Drugs market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
    Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
    Chemotherapy
    Targeted Therapy
    Immunotherapy (Biologic Therapy)
    Hormonal Therapy
    Others
    Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
    Amgen
    AstraZeneca
    Roche Diagnostics
    GlaxoSmithKline
    Merck
    Novartis
    AbbVie
    Sanofi
    EIMC United Pharmaceuticals
    Actavis
    Based on Application, the report describes major application share of regional market. Application mentioned as follows:
    Blood Cancer (Leukaemia)
    Breast Cancer
    Gastrointestinal Cancer
    Respiratory/Lung Cancer
    Skin Cancer
    Other Cancers
    Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
    Asia-Pacific
    North America
    Europe
    South America
    Middle East & Africa

    Buy now